Leading the Garden State in Business Analysis

  • Home
  • Lunch & Learn: Case Study: Building BA Excellence in a Distributed Organization

Lunch & Learn: Case Study: Building BA Excellence in a Distributed Organization

  • 06/24/2015
  • 12:00 PM - 1:00 PM
  • Virtual Event
  • 90


  • IIBA New Jersey chapter members. You must log in to access this registration type.
  • non-IIBA New Jersey members

Registration is closed

Case Study: Building BA Excellence in a Distributed Organization

Many business analysis experts debate whether business analysis professionals should be centralized in a common organization or distributed across teams to be integrated with the business areas that they support. In Pfizer’s Research & Development Business Technology organization, business analysts are distributed throughout the organization, with smaller groupings that are tightly tied to specific business lines and functions within Pfizer. To enable specialization in a business domain while still focusing on driving strong, targeted growth of the business analysis discipline, Pfizer created a Business Analysis Leadership Team in 2011. In this session Carol talks about the use of the Leadership Team approach at Pfizer and how it has helped improve the quality and success of business analysts in her organization. She also shares some of the challenges in establishing a strong, highly effective leadership team and her thoughts on how you can avoid some of them.
Learning Objectives:
  • Awareness on an approach to driving a discipline forward without centralization
  • How to build an effective leadership team
  • Challenges to overcome in establishing and maintaining a productive leadership team

About the presenter:

Carol Scalice-Miello

Carol Scalice is a Manager, Business Partner at Pfizer Pharmaceuticals in Groton, CT. She has several years of BA experience, including specialties in Enterprise Business Analysis and Agile Business Analysis, and a graduate degree in Industrial and Organizational Psychology. Carol has served on the BA Leadership Team at Pfizer and has led Pfizer's BA Community of Practice. In addition to spearheading Pfizer’s uptake of Agile Business Analysis in Research & Development Business Technology, she developed a reusable capability assessment framework used to create strategic roadmaps that drive IT portfolio decisions within Pfizer Global Research. Outside of Pfizer, Carol is one of the founders and President of the IIBA® Pharma/Biotech Special Interest Group, and a contributing author to both the IIBA®’s Agile and EBA Extensions to the BA Body of Knowledge.

Log-in instructions will be sent with the registration confirmation email.
PENDING/INCOMPLETE REGISTRATIONS will be removed if not completed the day before the event.
Powered by Wild Apricot. Try our all-in-one platform for easy membership management